Sola Security Launches Lumina, an Autonomous Security Deep Research Platform for Actionable Risk Intelligence
ESET reaffirms its global market presence with new European and Asian offices
ESET supercharges AI innovation with investment to address rapidly expanding attack surface
Advancing Open Source Patent Protection: Preservation of OIN 2.0 Source Code
Productized OS Launches Productized MasterClass to Transform Corporate Experience into 7-Figure Startups
Phase III VISION study with 177Lu-PSMA-617 met both primary endpoints, significantly improving overall survival (OS)…
Press Release Nicox’s NCX 470 Mont Blanc Phase 3 Glaucoma Trial Reaches 50% Enrollment Milestone…
For the First Time Scientific Data From a Certified Canadian Laboratory Answers This Fundamental Question….
Investigational antibody cocktail of casirivimab and imdevimab also significantly shortened the duration of symptoms by…
With eight new configurations, cobas pro® integrated solutions offers labs greater flexibility to ramp up…
NEW HAVEN, Conn., March 22, 2021 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the…
Expanding existing COVID-19 vaccine research collaboration which began in July 2020. Medytox and Dyadic to…
WEST CHESTER, Pa., March 22, 2021 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (Verrica) (NASDAQ: VRCA),…
EDISON, N.J., March 22, 2021 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA, “Hepion”), a clinical…
Blood Sugar Blaster is a sugar-regulating supplement that seeks to prevent the user from catching…
Bagsværd, Denmark, 22 March 2021 – Novo Nordisk today announced that the US Food and…
Company announcement – No. 16 / 2021 Zealand Pharma Announces FDA Approval of Zegalogue® (dasiglucagon)…
FOSTER CITY, Calif., March 22, 2021 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation…
CHARLESTON, S.C., March 22, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS)…
– Phase 2 RUN-HN trial showed ORR of 55%, median PFS of 5.6 months and…
SANTA MONICA, Calif., March 22, 2021 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a…
WEST CHESTER, Pa., March 22, 2021 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology…
YONKERS, N.Y., March 22, 2021 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology…
Dosing to stop in Phase III clinical study of tominersen following recommendation from an Independent…
— 33% of patients treated with efruxifermin (EFX) (4 of 12) improved by one fibrosis…